Health Canada
- Status: approved
🇨🇦 Continuous Pramlintide infusion in Canada
Continuous Pramlintide infusion (Continuous Pramlintide infusion) regulatory status in Canada.
Marketing authorisation
Continuous Pramlintide infusion in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Continuous Pramlintide infusion approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Continuous Pramlintide infusion in Canada?
University Diabetes & Endocrine Consultants is the originator. The local marketing authorisation holder may differ — check the official source linked above.